The Europe Cannabis Testing Market was valued at $351.3 Million in 2024 and projected to reach to $796 Million by 2029, representing a compound annual growth rate of 17.8%. Europe's cannabis testing market is poised for sustained expansion through 2029, driven by increasingly stringent regulatory requirements and the continent's shift toward legalization.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Europe's cannabis testing market is valued at $351.3 million in 2024 and is projected to reach $796.0 million by 2029, representing a robust 17.8% CAGR. This growth significantly outpaces many other European healthcare segments, driven by regulatory harmonization and quality assurance demands.
Germany dominates Europe's cannabis testing market with $195.8 million in market size, accounting for over 55% of the regional market. The country's advanced regulatory framework and established medical cannabis infrastructure position it as the continent's testing hub.
Progressive legalization in Germany, the Netherlands, and the UK is creating standardized testing requirements across Europe. These regulatory frameworks mandate comprehensive potency, pesticide, and microbial testing, directly fueling demand for specialized testing services and infrastructure.
Europe's cannabis testing market benefits from parallel expansion in both medical cannabis prescriptions and recreational legalization initiatives. This dual-segment growth creates diverse testing requirements across pharmaceutical-grade products and consumer-facing cannabis goods.
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | POTENCY TESTING SERVICES (Service) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 17.2% from 2024 to 2029 |
| Largest Segment | PRODUCTS (Product & Software) |
| Market Size Base Year (Billions) | ~USD 1.81 (2024) |
| Revenue Forecast (Billions) | ~USD 4 (2029) |
| Segments Covered | Product & Software, Type, Service, End User, Component |
5 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CANNABIS TESTING LABORATORIES | 106.3 | 118.2 | 129.8 | 147 | 169.3 | 196.7 | 229.6 | 267.9 | 15.6 |
| RESEARCH INSTITUTES | 17.1 | 18.7 | 20.2 | 22.5 | 25.4 | 29 | 33.2 | 38.1 | 13.6 |
| TOTAL | 123.4 | 136.9 | 150 | 169.5 | 194.7 | 225.7 | 262.8 | 306 | 15.3 |
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CANNABIS TESTING LABORATORIES | 45.3 | 50.1 | 54.8 | 61.7 | 70.7 | 81.7 | 94.9 | 110.2 | 15 |
| RESEARCH INSTITUTES | 7.3 | 7.9 | 8.5 | 9.4 | 10.6 | 12.1 | 13.8 | 15.7 | 13 |
| TOTAL | 52.6 | 58 | 63.3 | 71.1 | 81.3 | 93.8 | 108.7 | 125.9 | 14.8 |
| Country | 2025 size (native) |
|---|---|
| Germany | USD 195.8 Million |
| UK | USD 125.9 Million |
| France | USD 34 Million |
| Italy | USD 17.4 Million |
| Rest Of Europe | USD 113.9 Million |
Europe's cannabis testing market was valued at $351.3 million in 2024 and is projected to reach $796.0 million by 2029, representing a 17.8% compound annual growth rate.
Germany, the Netherlands, Switzerland, and other EU nations with legalized medical or recreational cannabis programs are primary growth drivers, as their regulatory frameworks mandate comprehensive testing protocols.
Europe's cannabis testing market prioritizes potency analysis, microbial contamination screening, pesticide residue detection, and heavy metal testing to comply with pharmaceutical-grade EU standards.
Europe's 17.8% CAGR exceeds the global average of 17.2%, indicating accelerated market maturation and stronger regulatory enforcement driving testing adoption across the continent.
EU regulatory harmonization initiatives, national legalization frameworks, and stringent quality compliance mandates are establishing standardized testing requirements that strengthen market professionalization and consumer confidence.
This study involved four major activities in estimating the current size of the cannabis testing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the cannabis testing market. The secondary sources used for this study include the International Cannabis and Cannabinoids Institute (ICCI), Association of Commercial Cannabis Laboratories (ACCL), American Medical Marijuana Association (AMMA), California Cannabis Industry Association (CCIA), Oregon Cannabis Association (OCA), Canadian National Medical Marijuana Association (CNMMA), World Health Organization (WHO), National Institutes of Health (NIH), National Center for Complementary and Integrative Health (NCCIH), American Oil Chemists’ Society (AOCS), Association of Public Health Laboratories (APHL), American Association for Clinical Chemistry (AACC), National Center for Biotechnology Information (NCBI), BioPharm International, EvaluatePharma, ScienceDirect, News Articles, Journals, Press Releases, Paid Databases, Expert Interviews, and MarketsandMarkets Analysis, among others. These sources were also used to obtain key information about major players, global product revenues, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data was collected and analyzed to arrive at the overall size of the global cannabis testing market, which was validated through primary research.
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Note: Tiers are defined based on a company’s total revenue. As of 2023, Tier 1 = >USD 1 Bn, Tier 2 = USD 500 Mn to USD 1 Bn, and Tier 3 <USD 500 Mn.
To know about the assumptions considered for the study, download the pdf brochure
The global size of the cannabis testing market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After estimating the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Cannabis raw material testing is crucial to quality assurance and regulatory compliance within the cannabis industry. It involves a comprehensive suite of analytical tests, products, and software to assess the safety, potency, and purity of cannabis plants or plant-derived materials before they are utilized in production processes. The key tests involved in cannabis testing include potency analysis, microbial screening, residual solvent testing, heavy metal analysis, pesticide residue testing, moisture content determination, terpene profiling, and foreign material inspection. The key products involved in cannabis testing include analytical and spectroscopy instruments, consumables, and software.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report with additional efforts:
Full forecast, segment splits, and company analysis for all Cannabis Testing Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report